Therefore, HDAC4 predicts the survival of ESCC patients independently of clinical stage, particularly in OS, indicating that HDAC4 can provide additional prognostic information for the clinical staging system. The gene discussed is HDAC4; the disease is esophageal squamous cell carcinoma.